Related Experiment Videos
Reevaluating the self-medication hypothesis among the dually diagnosed
Benjamin Henwood1, Deborah K Padgett
1New York University, School of Social Work, New York, NY 10003, USA. bfh205@nyu.edu
The American Journal on Addictions
|July 7, 2007
Summary
The self-medication hypothesis (SMH) is supported when considering substance use for general emotional pain, but not when limited to mental disorder symptoms. Understanding diverse substance use reasons is crucial.
Area of Science:
- Psychiatry
- Psychology
- Addiction Research
Background:
- The self-medication hypothesis (SMH) offers a common explanation for substance use.
- Its conceptual clarity is often lacking, especially for individuals with co-occurring mental and substance use disorders, hindering empirical evaluation.
- This ambiguity complicates assessing the validity of SMH in clinical populations.
Purpose of the Study:
- To evaluate the applicability of the self-medication hypothesis (SMH).
- To classify self-reported reasons for substance use among individuals with dual diagnosis and homelessness.
- To determine how conceptualizing SMH influences its empirical support.
Main Methods:
- Qualitative study involving 33 participants with dual diagnosis and homelessness.
- Analysis of self-reported reasons for substance use.
- Classification of substance use attributions based on different interpretations of SMH.
Main Results:
- When SMH is narrowly defined as coping with mental disorder symptoms, only 11 out of 72 attributions were supportive.
- When SMH is broadly defined as coping with general painful feelings, over half of all attributions supported the hypothesis.
- Findings highlight the impact of conceptual definitions on empirical validation.
Conclusions:
- The empirical support for the self-medication hypothesis (SMH) is contingent upon its definition.
- A broader conceptualization of SMH, encompassing coping with general emotional distress, aligns better with self-reported reasons for substance use.
- Accurate understanding of diverse motivations for substance use is vital for effective interventions.
Related Concept Videos
Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
Diagnostic and Statistical Manual of Mental Disorders (DSM)
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...